ITGB1 and cancer: This may be linked to the overexpression of ITGB1 in this cluster (Figure 5d), a multi-functional cell adhesion molecule that is known to trigger EMT and promote drug resistance in cancer cells [42], suggesting that integrin signaling inhibitors could also disrupt mesenchymal features and sensitize cells to doxorubicin.